Article Details
Retrieved on: 2022-12-28 07:55:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's immunotherapies Imfinzi and Imjudo have been approved in Japan for the treatment of three cancer types, it announced on Wednesday ...
Article found on: www.sharecast.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here